Association for Vascular Access (AVA) Works with TV Worldwide to Launch the 'AVA TV' Internet TV Channel
Channel Featuring 'Video for the Vascular Access Community' to Launch with Webcast of AVA Annual Scientific Meeting Live from National Harbor, Md., Sept. 7-10, 2014 at www.AVAInfo.TV
Washington, D.C., Aug. 13, 2014 (GLOBE NEWSWIRE) -- TV Worldwide, since 1999, a pioneering web-based global TV network, announced that it had teamed with the Association for Vascular Access (AVA) Association for Vascular Access (AVA) to launch the AVA TV- Video for the Vascular Access Community at www.AVAInfo.TV . The channel was launched in beta form on Tuesday, August 12, 2014 in preparation for full launch during the channel's live webcast of the AVA 2014 28th Annual Scientific Meeting, September 7-10, 2014 at National Harbor, Md. In addition to live webcast coverage of AVA events, AVA TV will feature a regular bi-monthly newscast and other interactive programming related to professional development, best practices and the latest advances in the vascular access community.
"We are pleased to have been selected to support an organization of the professional caliber of the Association for Vascular Access," said Dave Gardy, Chairman and CEO of TV Worldwide. "AVA has become renowned internationally for advancing research and providing professional and public education to shape practice and enhance patient outcomes and we look forward to supporting that mission through AVA TV." "We look forward to working with TV Worldwide as we launch the AVA TV Channel," stated Lee Grossman, CEO of the Association for Vascular Access. "This new Internet TV channel is integral to our strategy to bring about evidence-based innovations in vascular access." A pre-event webcast is scheduled for August 28, 2014 at 2 PM ET on AVA TV when activities and presentations at the upcoming Sept.7-10 Annual Scientific Meeting will be previewed.
About TV Worldwide
Founded in 1999, TV Worldwide.com, Inc. (t/a TV Worldwide, Inc., www.TVWorldwide.com) is a veteran-owned Internet TV solutions company that developed the first network of community-based Internet TV channels, primarily targeting niche enterprise/professional audiences ranging from the maritime industry to the telecom and federal/public sectors. Known by many in the industry as "Intelligent Internet TV," Fortune 500 companies, 35 federal government agencies, and numerous associations including the National Association of Broadcasters have partnered with TV Worldwide to utilize TV Worldwide's live and on-demand state-of-the art video streaming content applications and Internet TV channels. In recognition of the company's pioneering unique achievements in new media solutions and content development, TV Worldwide has been selected by the National Academy of Television Arts and Sciences (NATAS) to webcast past Daytime Emmy Awards and the Emmy awards for Technology and Engineering. TV Worldwide Chairman and CEO Dave Gardy, has been honored by Streaming Media Magazine as one of the 25 Most Influential People in Streaming Media. Mr. Gardy also has served as the President of the International Webcasting Association (IWA) and as a member of the Vietnam Veterans Memorial Fund Corporate Council.
About the Association for Vascular Access
The Association for Vascular Access (AVA) is an association of healthcare professionals founded in 1985 to promote the emerging vascular access specialty. Today, it's multidisciplinary membership advances research, professional and public education to shape practice and enhance patient outcomes, and partners with the device manufacturing community to bring about evidence-based innovation in vascular access. Learn more at (www.AVAInfo.org)
CONTACT: Sarah Selz TV Worldwide Inc. [email protected] www.TVWorldwide.com (703) 961-9250, ext. 247Source: TVWorldwide.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EliteSignals Unveils Revolutionary Forex Trading Bot: EliteX
- Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
- New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!